News
6d
MedPage Today on MSNEarly Rituximab Can Delay Need for Chemo in Follicular LymphomaLong-term results from a randomized trial confirmed that early rituximab monotherapy for advanced-stage, asymptomatic, low ...
Common Sense Oncology has developed principles designed to improve randomized phase 3 trials and ensure meaningful results. Recommendations address use of certain endpoints, toxicity reporting and ...
The UK Government should negotiate better regulations for clinical trials, drug imports, and employing European scientists to ...
Hosted on MSN17d
Redefining the future of clinical trials in oncologyNext month, experts from big and small pharmaceutical and biotech companies, contract research organisations ... GlobalData’s Director of Oncology and Hematology who will shed light on the ...
Medscape Oncology, March 28, 2025 COLLISION: Thermal Ablation in Colorectal Liver Metastases Prof David Kerr discusses a recent trial investigating ... January 02, 2025 UK’s Assisted Dying ...
One in six participants in phase 2 cancer trials received a therapy that gained FDA approval. The results demonstrate phase 1 trials help filter out unsafe or ineffective drugs, investigators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results